ASSESSMENT OF ANTI-TUMOR EFFICACY OF OSIMERTINIB IN NON-SMALL CELL LUNG CANCER PATIENTS BY LIQUID BIOPSY USING BRONCHOALVEOLAR LAVAGE FLUID, PLASMA, OR PLEURAL EFFUSION